Acceptability of palliative care approaches for patients with severe and persistent mental illness: a survey of psychiatrists in Switzerland.
Adult
Aged
Aged, 80 and over
Chronic Disease
Cross-Sectional Studies
Female
Humans
Male
Mental Disorders
/ epidemiology
Middle Aged
Palliative Care
/ methods
Patient Acceptance of Health Care
/ psychology
Psychiatry
/ methods
Quality of Life
/ psychology
Surveys and Questionnaires
Switzerland
/ epidemiology
Futility
Goals of care
Palliative care
Palliative psychiatry
Quality of life
Severe and persistent mental illness
Treatment-refractoriness
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
11 04 2019
11 04 2019
Historique:
received:
22
02
2018
accepted:
27
03
2019
entrez:
13
4
2019
pubmed:
13
4
2019
medline:
22
1
2020
Statut:
epublish
Résumé
Some patients develop severe and persistent mental illness (SPMI) which is therapy-refractory. The needs of these patients sometimes remain unmet by therapeutic interventions and they are at high risk of receiving care that is inconsistent with their life goals. Scholarly discourse has recently begun to address the suitability of palliative care approaches targeting at enhancing quality of life for these patients, but remains to be developed. A cross-sectional survey asked 1311 German-speaking psychiatrists in Switzerland (the total number of German-speaking members of the Swiss Society for Psychiatry and Psychotherapy) about the care of SPMI patients in general, and about palliative care approaches in particular. 457 (34.9%) returned the completed survey. In addition, participants were asked to evaluate three case vignettes of patients with SPMI. The reduction of suffering and maintaining daily life functioning of the patient were rated as considerably more important in the treatment of SPMI than impeding suicide and curing the underlying illness. There was broad agreement that SPMI can be terminal (93.7%), and that curative approaches may sometimes be futile (e.g. 72.4% for the anorexia nervosa case vignette). Furthermore, more than 75% of the participating psychiatrists were in favour of palliative care approaches for SPMI. The results of the present study suggest that the participating psychiatrists in Switzerland regard certain forms of SPMI as posing high risk of death. Additionally, a majority of respondents consider palliative care approaches appropriate for this vulnerable group of patients. However, the generalizability of the results to all psychiatrists in Switzerland or other mental health professionals involved in the care of SPMI is limited. This limitation is important considering the reservations towards palliative care in the context of psychiatric illness, mainly because of the association with death and futility. Palliative care approaches, however, are applicable in conjunction with other therapies intended to prolong life. A next step could be to involve service users and develop a consensus of what palliative care might encompass in SPMI. A framework for identifying which patients might benefit from palliative care, should be explored for the future development of care for SPMI patients.
Sections du résumé
BACKGROUND
Some patients develop severe and persistent mental illness (SPMI) which is therapy-refractory. The needs of these patients sometimes remain unmet by therapeutic interventions and they are at high risk of receiving care that is inconsistent with their life goals. Scholarly discourse has recently begun to address the suitability of palliative care approaches targeting at enhancing quality of life for these patients, but remains to be developed.
METHOD
A cross-sectional survey asked 1311 German-speaking psychiatrists in Switzerland (the total number of German-speaking members of the Swiss Society for Psychiatry and Psychotherapy) about the care of SPMI patients in general, and about palliative care approaches in particular. 457 (34.9%) returned the completed survey. In addition, participants were asked to evaluate three case vignettes of patients with SPMI.
RESULTS
The reduction of suffering and maintaining daily life functioning of the patient were rated as considerably more important in the treatment of SPMI than impeding suicide and curing the underlying illness. There was broad agreement that SPMI can be terminal (93.7%), and that curative approaches may sometimes be futile (e.g. 72.4% for the anorexia nervosa case vignette). Furthermore, more than 75% of the participating psychiatrists were in favour of palliative care approaches for SPMI.
CONCLUSIONS
The results of the present study suggest that the participating psychiatrists in Switzerland regard certain forms of SPMI as posing high risk of death. Additionally, a majority of respondents consider palliative care approaches appropriate for this vulnerable group of patients. However, the generalizability of the results to all psychiatrists in Switzerland or other mental health professionals involved in the care of SPMI is limited. This limitation is important considering the reservations towards palliative care in the context of psychiatric illness, mainly because of the association with death and futility. Palliative care approaches, however, are applicable in conjunction with other therapies intended to prolong life. A next step could be to involve service users and develop a consensus of what palliative care might encompass in SPMI. A framework for identifying which patients might benefit from palliative care, should be explored for the future development of care for SPMI patients.
Identifiants
pubmed: 30975122
doi: 10.1186/s12888-019-2091-x
pii: 10.1186/s12888-019-2091-x
pmc: PMC6458682
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111Références
World Psychiatry. 2017 Feb;16(1):30-40
pubmed: 28127922
Schizophr Bull. 1990;16(4):551-61
pubmed: 1981813
World Psychiatry. 2017 Feb;16(1):48-49
pubmed: 28127904
Aust N Z J Psychiatry. 2012 Feb;46(2):170-2
pubmed: 22311533
Am J Bioeth. 2015;15(7):47-50
pubmed: 26147266
JAMA Psychiatry. 2015 Dec;72(12):1172-81
pubmed: 26509694
Aust N Z J Psychiatry. 2012 Feb;46(2):92-9
pubmed: 22311525
BMC Med. 2017 Aug 2;15(1):139
pubmed: 28764757
Am J Bioeth. 2015;15(7):59-60
pubmed: 26147271
Am J Bioeth. 2015;15(7):34-43
pubmed: 26147264
J Clin Psychiatry. 2017 Jul;78(7):e852-e857
pubmed: 28749092
Ann Gen Psychiatry. 2013 May 30;12(1):17
pubmed: 23718899
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Am J Bioeth. 2017 Apr;17(4):15-17
pubmed: 28328373
Int Clin Psychopharmacol. 2014 Mar;29(2):63-76
pubmed: 23995856
Int J Eat Disord. 2010 May;43(4):372-7
pubmed: 19444903
BMC Psychiatry. 2016 Jul 22;16:260
pubmed: 27450328
World Psychiatry. 2017 Jun;16(2):200-206
pubmed: 28498576
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Am J Bioeth. 2015;15(7):55-6
pubmed: 26147269
Schizophr Bull. 2015 May;41(3):664-73
pubmed: 25262443
Am J Psychiatry. 2013 Sep;170(9):1059-61
pubmed: 24030616
Kidney Int. 2015 Sep;88(3):447-59
pubmed: 25923985
Am J Bioeth. 2015;15(7):53-4
pubmed: 26147268
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783